Introduction
Woods et all examined the distribution of age and parity of 341 patients with breast cancer attending a single clinic. They found that the mean age at presentation was lower in parous than nulliparous women and fell with increasing parity until it levelled off in those having had three or more children. There are difficulties, however, in examining the mean age at which events occur in different groups of a population. Over a 100 years ago Farr,' when discussing this, pointed out that the mean age at death of curates was considerably lower than the mean age at death of bishops: but this reflected the different age distribution of the two subgroups of the population rather than the differences in the risk of disease in the two groups. Census being restricted to live births. Also the data suffered from a degree of non-response, as some women failed to record either marital state or parity in the schedule. There was no way of correcting for this, but probably the slight underreporting did not seriously bias the distribution by age or parity.
The age-specific incidence of breast cancer for women in England and Wales in 19755 was applied to the age distributions derived above to obtain expected numbers of cases. It was then a simple matter to calculate the estimated mean age at development of breast cancer within each parity. Though there was evidence for a variation in risk of breast cancer by parity, the use ofthe incidence figures for all women created no problem in estimating the mean age at diagnosis, provided that the relative risk in different parity groups was constant over age.
This may be shown as follows: average age of breast cancer in parity subgroup = (Pi (Bi RR) Ai)/(Pi (Bi RR)), where Pi =number of women in parity and age group, Bi =incidence of breast cancer in age group, Ai= age groups from 20-24 to >85, and RR=relative risk for specific parity. If the relative risk was constant at all age groups for any given parity it had no influence on the average age, as it could be cancelled from both the numerator and the denominator.
Results
The women at young ages, as one would expect; there was also a somewhat higher proportion aged over 70 compared with 30-69 years. There has been a tendency for the proportion of women having very large families to decrease, and this was again reflected by an increased proportion of women in the high parous group at older ages. The data were originally examined for those having three, four, or five or more children; it was particularly in those having five or more children that the proportion at the older age groups was higher.
One crucial point about this study is whether it was appropriate to assume that the relative risk of breast cancer is constant within parity subgroups over a wide age range; unfortunately this issue has not been adequately quantified. The nearest set of data most relevant to this was a study by Miller et al, 6 who examined the parity for women in three provinces in Canada registered with all forms of malignant disease in 1969-71. By special inquiry parity for these women was obtained and compared with the census data. The relative risk of breast cancer in women having four or more children compared with nulliparae was similar in the age ranges 20-44, 45-54, and 55 years and over.
Applying England and Wales incidence rates to the age distribution of women by parity enabled the average age at diagnosis to be estimated; the results approximate to the findings of Woods et al.1 It was suggested that their result was a reflection of variation in the age distribution of women by parity, rather than any particular influence of parity on accelerating or slowing the date of presentation of breast cancer.
Introduction
The increased physiological requirement for calcium during pregnancy presents a major challenge to maternal calcium homoeostasis. The needs of the growing fetus have to be supplied but at the same time maternal bone and plasma calcium concentrations have to be maintained. If both these conditions are to be fulfilled changes in the secretion of calciumregulating hormones must occur.
To determine the gestational changes in the secretion of calcium-regulating hormones we measured the plasma concentrations of calcitonin, parathyroid hormone, and the vitamin D metabolites 25-hydroxyvitamin D (25-OHD) and 1,25-dihydroxyvitamin D (1,25-(OH),D) on four occasions during entirely normal pregnancies in a cross-sectional study. Previous studies either have been conducted only at the end of pregnancy or have been incomplete as important hormones have not been measured and details of the obstetric outcome have invariably been lacking. Thus the full interrelations of the calciumregulating hormones in normal pregnancy have not been shown.
